Stanford researchers have invented a twist-expand mechanical bioreactor that provides an appropriate in vitro microenvironment for induced pluripotent stem cell (iPSC) derived cardiomyocytes to achieve biomimetic anisotropic alignment and form contractile cardiac tissue
Stanford researchers have engineered hematopoietic stem cells to provide long-term secretion of chosen therapeutic antibodies, eliminating the need of repeated dosing for delivery.
Researchers at Stanford University have developed a novel kidney stone extraction device that can be used during ureteroscopy to simultaneously remove kidney stone fragments and dust without affecting renal pressure.
Researchers in Dr. Michelle Monje-Deisseroth's lab at Stanford have identified therapeutic targets for drug development to limit the spread of high-grade gliomas (HGGs).
Stanford scientists have developed PVSeg, a tool that automatically segments vascular and perivascular compartments in brain MRI data. This innovative tool can identify non-demented individuals at increased risk of developing dementia and accelerated brain atrophy.
Stanford scientists have developed a device to distinguish the molecule-specific signatures of diseased exosomes isolated from glioblastoma patients. The device is portable, disposable, and low-cost, enabling point-of-care assessment of disease.
Researchers in the Airan Lab have developed a noninvasive method using low intensity transcranial ultrasound to drive cerebrospinal fluid (CSF) glymphatic and lymphatic flow to clear brain injury waste products from CSF and brain interstitium.
Stanford researchers have developed a predictive biomarker for hepatocellular carcinoma (HCC) recurrence post-treatment that provides key spatial distribution information about cell interaction.
Typically, cell live imaging and cell molecular profiling are performed on two different samples without the direct observation of two modalities of information on the exact same cells.
Among the many medical imaging modalities, CT and MRI scans are utilized most often for imaging bone and soft tissue respectively. As such, physicians often require both images to fully diagnose patients and determine treatment plans.
Researchers at Stanford University and Washington University in St. Louis have discovered a novel molecular pathway for the treatment of opioid overdose.